Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Hypochondroplasia gain-of-function mutation in FGFR3 causes defective bone mineralization in mice
Léa Loisay, Davide Komla-Ebri, Anne Morice, Yann Heuzé, Camille Viaut, Amélie de La Seiglière, Nabil Kaci, Danny Chan, Audrey Lamouroux, Geneviève Baujat, J.H. Duncan Bassett, Graham R. Williams, Laurence Legeai-Mallet
Léa Loisay, Davide Komla-Ebri, Anne Morice, Yann Heuzé, Camille Viaut, Amélie de La Seiglière, Nabil Kaci, Danny Chan, Audrey Lamouroux, Geneviève Baujat, J.H. Duncan Bassett, Graham R. Williams, Laurence Legeai-Mallet
View: Text | PDF
Research Article Bone biology Genetics

Hypochondroplasia gain-of-function mutation in FGFR3 causes defective bone mineralization in mice

  • Text
  • PDF
Abstract

Hypochondroplasia (HCH) is a mild dwarfism caused by missense mutations in fibroblast growth factor receptor 3 (FGFR3), with the majority of cases resulting from a heterozygous p.Asn540Lys gain-of-function mutation. Here, we report the generation and characterization of the first mouse model (Fgfr3Asn534Lys/+) of HCH to our knowledge. Fgfr3Asn534Lys/+ mice exhibited progressive dwarfism and impairment of the synchondroses of the cranial base, resulting in defective formation of the foramen magnum. The appendicular and axial skeletons were both severely affected and we demonstrated an important role of FGFR3 in regulation of cortical and trabecular bone structure. Trabecular bone mineral density (BMD) of long bones and vertebral bodies was decreased, but cortical BMD increased with age in both tibiae and femurs. These results demonstrate that bones in Fgfr3Asn534Lys/+ mice, due to FGFR3 activation, exhibit some characteristics of osteoporosis. The present findings emphasize the detrimental effect of gain-of-function mutations in the Fgfr3 gene on long bone modeling during both developmental and aging processes, with potential implications for the management of elderly patients with hypochondroplasia and osteoporosis.

Authors

Léa Loisay, Davide Komla-Ebri, Anne Morice, Yann Heuzé, Camille Viaut, Amélie de La Seiglière, Nabil Kaci, Danny Chan, Audrey Lamouroux, Geneviève Baujat, J.H. Duncan Bassett, Graham R. Williams, Laurence Legeai-Mallet

×

Figure 4

Analyses of the cartilage growth plate and the secondary ossification center (SOC).

Options: View larger image (or click on image) Download as PowerPoint
Analyses of the cartilage growth plate and the secondary ossification ce...
(A) H&E staining of femur distal growth plate on P14 and P21 showing SOC delay and reduced hypertrophic cartilage area. HZ, hypertrophic zone. Scale bars: 200 μm and 50 μm (zoomed-in images). (B) Left: Visualization of SOC of the distal femur. Scale bar: 1000 μm. Right: Graphical representation of the SOC/epiphysis volume ratio in Fgfr3+/+ (n = 5) and Fgfr3Asn534Lys/+ (n = 5) male and female mice. (C) Left: Collagen type X (Col X) immunostaining. Scale bar: 50 μm. Right: Graphical representation of mean cell area in Col X+ area in Fgfr3+/+ (n = 7) and Fgfr3Asn534Lys/+ (n = 6) male and female mice. (D) Ki67+ cells/total cells (DAPI+) on P14 in Fgfr3+/+ (n = 6) and Fgfr3Asn534Lys/+ (n = 7) male and female mice, BrdU+ cells/DAPI+ cells on P14 in Fgfr3+/+ (n = 7) and Fgfr3Asn534Lys/+ (n = 7), and BrdU+ cells/DAPI+ cells on P21 in Fgfr3+/+ (n = 5) and Fgfr3Asn534Lys/+ (n = 5) male and female mice. (E) Left: p-Erk1/2 immunostaining on P14 growth plate. Scale bar: 50 μm. Graphical representation of relative intensity of p-Erk1/2 on Fgfr3+/+ (n = 5) and Fgfr3Asn534Lys/+ (n = 7) male and female growth plates. Representative Western blots of p-Erk1/2 (left) and Erk1/2 in primary chondrocytes with FGF2 stimulation over time (0, 5, 30, 60, 120 minutes), from 4 independent Western blots with (n = 5 mice per group). Graphical representation of p-Erk1/2/Erk1/2 ratio over time. NS, not significant; *P < 0.05 by Mann-Whitney test (B–D and left graph in E) or 2-way ANOVA with Šidák’s multiple-comparison test (right graph in E [p-Erk1/2/Erk1/2 ratio over time]).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts